Assembly Biosciences (ASMB)
(Real Time Quote from BATS)
$12.51 USD
-0.84 (-6.29%)
Updated Jul 3, 2024 09:30 AM ET
3-Hold of 5 3
B Value B Growth B Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/14/24 |
---|---|
Current Quarter | -2.96 |
EPS Last Quarter | -1.66 |
Last EPS Surprise | 39.42% |
ABR | 2.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -12.65 |
Next Year | -13.45 |
EPS (TTM) | -17.05 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 5.96M | 6.14M | 24.20M | 29.04M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 5.96M | 6.14M | 24.20M | 29.04M |
Low Estimate | 5.96M | 6.14M | 24.20M | 29.04M |
Year ago Sales | 0.00M | 0.00M | 7.16M | 24.20M |
Year over Year Growth Est. | NA | NA | 237.85% | 20.00% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -2.96 | -3.29 | -12.65 | -13.45 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -2.96 | -3.29 | -12.65 | -13.45 |
High Estimate | -2.96 | -3.29 | -12.65 | -13.45 |
Low Estimate | -2.96 | -3.29 | -12.65 | -13.45 |
Year ago EPS | -3.84 | -3.24 | -13.38 | -12.65 |
Year over Year Growth Est. | 22.92% | -1.54% | 5.46% | -6.32% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -2.96 | -3.29 | -12.65 | -13.45 |
7 Days Ago | -2.96 | -3.29 | -12.65 | -13.45 |
30 Days Ago | -2.96 | -3.29 | -12.65 | -13.45 |
60 Days Ago | -2.96 | -3.29 | -12.65 | -13.45 |
90 Days Ago | -2.96 | -3.29 | -12.65 | -13.45 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -2.96 | -3.29 | -12.65 | -13.45 |
Zacks Consensus Estimate | -2.96 | -3.29 | -12.65 | -13.45 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.66 | NA | -3.24 | -3.84 | NA |
Estimate | -2.74 | NA | -2.76 | -3.48 | NA |
Difference | 1.08 | NA | -0.48 | -0.36 | 0.08 |
Surprise | 39.42% | NA | -17.39% | -10.34% | 3.90% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more